Journal Information
Vol. 17. Issue 1.
Pages 7-14 (January - February 2011)
Vol. 17. Issue 1.
Pages 7-14 (January - February 2011)
Open Access
Hemoptises-etiologia, avaliação e tratamento num hospital universitário
Hemoptysis — etiology, evaluation and treatment in a university hospital
Visits
16844
F. Soares Pires
Corresponding author
filipasp@gmail.com

Autor para correspondência.
, N. Teixeira, F. Coelho, C. Damas
Serviço de Pneumologia, Hospital de São João, Porto, Portugal
This item has received

Under a Creative Commons license
Article information
Resumo
Objectivo

Avaliar doentes admitidos por hemoptises quanto à etiologia, meios diagnósticos, tratamento e evolução.

Material e métodos

Realizou-se um estudo retrospectivo dos doentes admitidos no Hospital de São João, por hemoptises, entre 01 de Janeiro de 2004 e 31 de Dezembro de 2008.

Resultados

Foram estudados 237 doentes, com idade média de 57.9 anos. Nos doentes com idade inferior a 18 anos, os diagnósticos mais frequentes foram Bronquiectasias e Cardiopatia congénita. Nos adultos, as Sequelas de Tuberculose Pulmonar e as Bronquiectasias foram os diagnósticos predominantes (22.2% e 15.8%, respectivamente), seguidos pela neoplasia pulmonar. A infecção foi responsável pelas perdas hemáticas em 51 doentes, essencialmente Tuberculose Pulmonar, Pneumonia e Traqueobronquite. A etiologia ficou por esclarecer em 6.3%.

Todos os doentes realizaram radiografia de tórax. A TAC foi realizada em 81.4% dos doentes e a Broncofibroscopia em 52.7%, esta última localizando a fonte da hemorragia em 38.4% e estabelecendo diagnóstico definitivo em 17.6%.

Na maioria dos casos (90.7%), a hemorragia foi controlada com tratamento médico. Ao longo destes 5 anos, 11.8% dos doentes foram submetidos a embolização arterial, sendo a prevenção de recidiva o principal motivo da sua realização.

Foram registados 14 óbitos (5,9%), sendo identificados, como factores de mau prognóstico, a instabilidade hemodinâmica e a etiologia neoplásica.

Conclusão

As hemoptises continuam a ser um sintoma frequente, sendo actualmente as sequelas associadas a infecções crónicas e as neoplasias as principais etiologias. Neste estudo, os factores de pior prognóstico foram a instabilidade hemodinâmica e a etiologia neoplásica.

Palavras-chave:
Hemoptises
Etiologia
Diagnóstico
Tratamento
Abstract
Objective

Evaluate patients admitted for hemoptysis, its etiology, use of diagnostic tests, treatment and outcome.

Methods

A retrospective analysis was done, checking clinical files of patients admitted for hemoptysis, between 1st January 2004 and 31st December 2008.

Results

Two hundred and thirty seven patients were included in this study, with a mean age of 57.9 years. In patients under 18 years, the most frequent diagnoses were Bronchiectasis and Congenital Cardiopathy. In adults, Pulmonary Tuberculosis Sequelae and Bronchiectasis were the dominant diagnoses (22.2% and 15.8%, respectively), followed by Lung Cancer. Active infection was responsible for bleeding in 51 patients, especially Pulmonary Tuberculosis, Pneumonia and Tracheobronchitis. The etiology of hemoptysis was not established in 6.3%.

All patients performed chest X-Ray. Chest CT was performed in 81.4% of patients and Fiberoptic bronchoscopy in 52.7%, the latter locating the source of bleeding in 38.4% and establishing a final diagnosis in 17.6%.

In most patients, effective control of bleeding was achieved by medical treatment (90.7%).

During these 5 years, arterial embolization was performed in 11.8% of patients. The main reason for embolization was recurrence prevention.

There were 14 deaths (5.9%), being identified as poor prognostic factors, hemodynamic instability and malignancy.

Conclusion

Hemoptysis is still a frequent symptom, being chronic infection sequelae and lung cancer their main causes. In this study, factors associated with a worse prognosis were hemodynamic instability and malignancy.

Keywords:
Hemoptysis
Etiology
Diagnosis
Treatment
Full text is only aviable in PDF
Bibliografia
[1.]
W. Reechaipichitkul, S. Latong.
Etiology and treatment outcomes of massive hemoptysis. Southeast Asian.
J Trop Med Public Health, 36 (2005), pp. 474-480
[2.]
E. Unsal, D. Köksal, F. Cimen, et al.
Analysis of patients with hemoptysis in a reference hospital for chest diseases.
Tuberk Toraks, 54 (2006), pp. 34-42
[3.]
C.M. Wong, K.H. Lim, C.K. Liam.
The causes of hemoptysis in Malaysian patients aged over 60 and the diagnostic yield of different investigations.
Respirology, 8 (2003), pp. 65-68
[4.]
R. Prasad, R. Garg, S. Singhal, et al.
Lessons from patients with hemoptysis attending a chest clinic in India.
Ann Thorac Med, 4 (2009), pp. 10-12
[5.]
M. Porzezinska, A. Gorzewska, J. Drozdowski, et al.
Assessment of hemoptysis etiology among patients hospitalized in Pneumonology Department of Medical University of Gdansk in the years 1998–2002.
Pol Arch Med Wewn, 114 (2005), pp. 658-663
[6.]
M. Tsoumakidou, G. Chrysofakis, I. Tsiligianni, et al.
A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy.
Respiration, 73 (2006), pp. 808-814
[7.]
N. Takahashi, H. Akusawa, A. Kisohara, et al.
A clinical review of hemoptysis.
Journal of the Japan Broncho-Esophagological Society, 50 (1999), pp. 391-395
[8.]
Direcção Geral de Saúde, Programa Nacional de Luta Contra a Tuberculose (PNT), 2006 [Disponível em www.dgs.pt].
[9.]
Observatório Português dos Sistemas de Saúde. Controlo da Tuberculose em Portugal. Apreciação crítica epidemiológica relativa a 2006/2007 [Disponível em www.observaport.org/OPSS/Menus/Sistema/Tracers/].
[10.]
J.A. Coss-Bu, R.C. Sachdeva, J.T. Bricker, et al.
Hemoptysis: a 10-year retrospective study.
Pediatrics, 100 (1997), pp. e7
[11.]
S. Godfrey.
Pulmonary hemorrhage /hemoptysis in children.
Pediatr Pulmonol, 37 (2004), pp. 476-484
[12.]
D.J. Roebuck, A.M. Barnacle.
Hemoptysis and bronchial artery embolization in children.
Paediatr Respir Rev, 9 (2008), pp. 95-104
[13.]
K.S. Wong, R. Lien, S.H. Hsia.
Major hemoptysis in adolescents.
Indian J Pediatr, 72 (2005), pp. 537-538
[14.]
M. Thirumaran, R. Sundar, I.M. Sutcliffe, et al.
Is investigation of patients with haemoptysis and normal chest radiograph justified?.
Thorax, 64 (2009), pp. 854-956
[15.]
F. Laurent, M. Martins, A. Santy.
Hemoptysis: methods of localization.
Rev Med Suisse, 1 (2005), pp. 2659-2663
[16.]
M. Allewelt, H. Lode.
Diagnosis oh haemoptoe/haemoptysis.
Dtsch Med Wochenschr, 130 (2005), pp. 450-452
[17.]
J. Moura e Sá.
Hemoptises graves/maciças-a intervenção do pneumologista.
Rev Port Pneumol, 6 (2008), pp. S227
[18.]
G.T. Law, C.Y. Wong, Y.C. Chen, et al.
Cost-effectiveness of CT thorax and bronchoscopy in haemoptysis with normal CXR for exclusion of lung cancer.
Australas Radiol, 46 (2002), pp. 381-383
[19.]
B. Hirshberg, I. Biran, M. Glazer, et al.
Hemoptysis: etiology, evaluation, and outcome in a terciary referral hospital.
Chest, 112 (1997), pp. 440-444
[20.]
G. McGuinness, J.R. Beacher, T.J. Harkin, et al.
Hemoptysis: prospective high-resolution CT/bronchoscopic correlation.
Chest, 105 (1994), pp. 1155-1162
[21.]
P.E. Andersen.
Imaging and interventional radiological treatment of hemoptysis.
Acta Radiol, 47 (2006), pp. 780-792
[22.]
S.E. Weinberger.
Etiology and evaluation of hemoptysis in adults.
Uptodate,
[23.]
A. Valipour, A. Kreuzer, H. Koller, et al.
Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis.
Chest, 127 (2005), pp. 2113-2118
[24.]
R. Ramakantan, V.G. Bandekar, M.S. Gandhi, et al.
Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization.
Radiology, 200 (1996), pp. 691-694
[25.]
N. Tanaka, K. Yamakado, S. Murashima, et al.
Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system.
J Vasc Interv Radiol, 8 (1997), pp. 65-70
[26.]
V.L. Chan, L.K. So, J.Y. Lam, et al.
Major hemoptysis in Hong Kong: aetiologies, angiographic fi ndings and outcomes of bronchial artery embolisation.
Int J Tuberc Lung Dis, 13 (2009), pp. 1167-1173
[27.]
J.Y. Chun, A.M. Belli.
Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management oh haemotpysis.
Eur Radiol., (2009),
[28.]
S. Lee, J.W. Chan, S.C. Chan, et al.
Bronchial artery embolisation can be equally safe and effective in the management of chronic recurrent haemotpysis.
Hong Kong Med J, 14 (2008), pp. 14-20
[29.]
L. Menchini, M. Remy-Jardin, J.B. Faivre, et al.
Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients.
Eur Respir J, 34 (2009), pp. 1031-1039
[30.]
A. Parrot, A. Khalil, S. Roques, et al.
Management of severe hemoptysis: experience in a specialized center.
Rev Pneumol Clin, 63 (2007), pp. 202-210
[31.]
Y.G. Kim, H.K. Yoon, G.Y. Ko, et al.
Long-term effect of bronchial artery embolization in Korean patients with haemoptysis.
Respirology, 11 (2006), pp. 776-781
[32.]
S. Osaki, Y. Nakanishi, H. Wataya, et al.
Prognosis of bronchial artery embolisation in the management of hemoptysis.
Respiration, 67 (2000), pp. 412-416
[33.]
J.L. Lordan, A. Gascoigne, P.A. Corris.
The pulmonary physician in critical care * Illustrative case 7: assessment and management of massive haemoptysis.
Thorax, 58 (2003), pp. 814-819
[34.]
J.A. Ros Lucas, D. Malia Alvarado, B. Fernández Suárez, et al.
Hemoptisis: revisión de 70 casos.
Emergencias, 18 (2006), pp. 87-93
[35.]
F. Molinié, M. Velten, L. Remontet, et al.
The progression of lung cancer incidence in France (1978–2000).
Rev Mal Respir, 23 (2006), pp. 127-134
[36.]
M. Wahbah, N. Boroumand, C. Castro, et al.
Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases.
Ann Diagn Pathol, 11 (2007), pp. 89-96
[37.]
C. Kolappan, P.G. Gopi.
Tobacco smoke and pulmonary tuberculosis.
Thorax, 57 (2002), pp. 964-966
[38.]
M.N. Bates, A. Khalakdina, M. Pai, et al.
Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis.
Arch Intern Med, 167 (2007), pp. 335-342
[39.]
A. Garzon, M.M. Cerruti, M.E. Golding.
Exsanguinating hemoptysis.
J Thor Cardiovasc Surg, 84 (1982), pp. 829-833
[40.]
S. Endo, S. Otani, T. Hasegawa.
Management of massive hemoptysis in a thoracic surgical unit.
Eur J Cardiothorac Surg, 23 (2003), pp. 467-472
[41.]
E. Jean-Baptiste.
Clinical assessment and management of massive hemoptysis.
Crit Care Med, 28 (2000), pp. 1642-1647
[42.]
D.H. Ingbar.
Causes and management of massive hemoptysis in adults.
Uptodate,
[43.]
B. Tunçözgür, A.F. Isik, I. Nacak, et al.
Dilemma on the treatment of haemoptysis: an analysis of 249 patients.
Acta Chir Belg, 107 (2007), pp. 302-306
Copyright © 2011. Sociedade Portuguesa de Pneumologia
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?